Ledger.Open graph →

SEC Form D · Amendment · filed December 30, 2016

VASCULAR THERAPIES INC

Offering

$31.0M

Sold

$31.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

Cresskill, NJ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Michael Bamberger · Cresskill, NJDirector Somu Subramaniam · Cresskill, NJDirector Sriram Iyer · Cresskill, NJExec · Director Robert Flanagan · Cresskill, NJDirector Gerald Dorros · Cresskill, NJDirector Kiyoshi Takesue · Cresskill, NJDirector Robert Croce · Cresskill, NJDirector Allan Tessler · Cresskill, NJDirector Jonathan Q. Tran · San Francisco, CADirector Mohammed A. Kharazmi · Irvine, CADirector Robert Flanagan · Cresskill, NJDirector Michael Oberlander · Alamo, CADirector Mike Ricci · Alamo, CADirector Brian H. Loo · San Francisco, CAExec · Director Gregory J. Duman · Omaha, NEDirector Bruce Morgan · Alamo, CADirector Douglas S. Alexander · LONDON, Ontario, CanadaDirector Bruno S. Maruzzo · LONDON, Ontario, CanadaDirector Sriram Iyer · Cresskill, NJExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗